Investing Profile

Wende Hutton

VCInvestor

General Partner at Canaan Partners

canaan.com/team/wende-huttonMenlo Park, California
Photo of Wende Hutton, General Partner at Canaan Partners
Your Intro Paths to Wende Hutton

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →

Find Wende Hutton on

cb
Current Investing Position
Canaan Partners General Partner
Investment Range
$250K - $20.0M
Sweet Spot
$10.0M
Investments On Record
44
Current Fund Size
$800M

Wende Hutton is on these Sector & Stage Rankings

Wende Hutton's Investments On Record (18)

CompanyStageDateRound SizeTotal Raised
OncoResponse
Series CMar 2021$41M
Series AMay 2016$13M
$53M
Hyalex Orthopaedics
Series AMar 2019$17M
Series AMay 2017$16M
$33M
Co-investors: Bill Harrington (Osage University Partners), Renee Compton Ryan (Johnson & Johnson Innovation), V.Kadir Kadhiresan (Johnson & Johnson Innovation)
Glooko
Series CJun 2017$35M
Series CSep 2016$8M
Series BMar 2015$17M
$72M
Co-investors: Chamath Palihapitiya (Social Capital), Venky Harinarayan (rocketship.vc), David Carrico (Jlabs), Ted Maidenberg (Tribe Capital), Anand Rajaraman (rocketship.vc), Sundeep Madra, Bill Campbell
Antiva Biosciences
Series CMar 2017$22M
Series BAug 2015$16M
$38M
ReVision Optics
Venture RoundNov 2016$32M
Series EJul 2013$55M
Series EApr 2013$15M
Series DJul 2010$35M
$160M
Co-investors: Gil Kliman (InterWest), Reza Zadno (InterWest), Renee Compton Ryan (Johnson & Johnson Innovation), Brian Dovey (Domain Associates)
Chrono Therapeutics
Series BSep 2016$48M
Series AJun 2014$32M
$80M
Co-investors: James Young (5am Ventures), Cameron McLain (Giant Ventures), Liz Rockett (Kaiser Permanente Ventures)
ALDEA Pharmaceuticals
Series BAug 2014$24M
Venture RoundApr 2013$2M
$26M
Dermira
Series CAug 2014$51M
Series BJun 2013$35M
Series AOct 2011$42M
$130M
Co-investors: Jake Nunn (New Enterprise Associates (NEA))